skip to main content
Show Results with:

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

Drake, Marcus J. et al.

International journal of clinical practice. Volume 71:Issue 5 (2017); pp n/a-n/a -- John Wiley & Sons Inc

Online access

Notes here allow you and other users to comment and make notes on items, viewable by the whole community.
NB: Please use the Report Catalogue Error form to advise us of catalogue inaccuracies.

Log in to add a note

Tags allow you and others to define and search on related groups of items.

Log in to add / remove tags

Searching Remote Databases, Please Wait